Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (871-880 of 890) with videos related to

Pageof 89
Sort By:
Journal of the American Academy of Dermatology|November 10, 2019
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patientsAlan Menter, Kelly M Cordoro, Dawn M R Davis, et al.
Journal of the American Academy of Dermatology|August 2, 2020
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measuresCraig A Elmets, Neil J Korman, Elizabeth Farley Prater, et al.
Journal of the American Academy of Dermatology|March 3, 2020
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapiesAlan Menter, Joel M Gelfand, Cody Connor, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
JAMA Dermatology|November 21, 2019
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in PsoriasisAmit K Dey, Ranjitha Gaddipati, Youssef A Elnabawi, et al.
Journal of the American Academy of Dermatology|February 8, 2024
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis FoundationVipawee S Chat, Christoph T Ellebrecht, Paige Kingston, et al.
JAMA Neurology|May 1, 2018
Chronic Meningitis Investigated via Metagenomic Next-Generation SequencingMichael R Wilson, Brian D O'Donovan, Jeffrey M Gelfand, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
A Predictive Autoantibody Signature in Multiple SclerosisColin R Zamecnik, Gavin M Sowa, Ahmed Abdelhak, et al.
Science Immunology|November 21, 2020
Gut microbiota-specific IgA<sup>+</sup> B cells traffic to the CNS in active multiple sclerosisAnne-Katrin Pröbstel, Xiaoyuan Zhou, Ryan Baumann, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsAmanda C Guidon, Leeann B Burton, Bart K Chwalisz, et al.
Pageof 89

Showing results (871-880 of 890) with videos related to

Sort By:
Pageof 89
Journal of the American Academy of Dermatology|November 10, 2019
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patientsAlan Menter, Kelly M Cordoro, Dawn M R Davis, et al.
Journal of the American Academy of Dermatology|August 2, 2020
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measuresCraig A Elmets, Neil J Korman, Elizabeth Farley Prater, et al.
Journal of the American Academy of Dermatology|March 3, 2020
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapiesAlan Menter, Joel M Gelfand, Cody Connor, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
JAMA Dermatology|November 21, 2019
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in PsoriasisAmit K Dey, Ranjitha Gaddipati, Youssef A Elnabawi, et al.
Journal of the American Academy of Dermatology|February 8, 2024
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis FoundationVipawee S Chat, Christoph T Ellebrecht, Paige Kingston, et al.
JAMA Neurology|May 1, 2018
Chronic Meningitis Investigated via Metagenomic Next-Generation SequencingMichael R Wilson, Brian D O'Donovan, Jeffrey M Gelfand, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
A Predictive Autoantibody Signature in Multiple SclerosisColin R Zamecnik, Gavin M Sowa, Ahmed Abdelhak, et al.
Science Immunology|November 21, 2020
Gut microbiota-specific IgA<sup>+</sup> B cells traffic to the CNS in active multiple sclerosisAnne-Katrin Pröbstel, Xiaoyuan Zhou, Ryan Baumann, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsAmanda C Guidon, Leeann B Burton, Bart K Chwalisz, et al.
Pageof 89